These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 28233)

  • 1. Climbing behaviour induced by apomorphine in mice: a potential model for the detection of neuroleptic activity.
    Costall B; Naylor RJ; Nohria V
    Eur J Pharmacol; 1978 Jul; 50(1):39-50. PubMed ID: 28233
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterisation of the mechanisms by which purported dopamine agonists reduce spontaneous locomotor activity of mice.
    Costall B; Lim SK; Naylor RJ
    Eur J Pharmacol; 1981 Jul; 73(2-3):175-88. PubMed ID: 6118281
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gabaminergic and serotonergic modulation of the antidyskinetic effects of tiapride and oxiperomide in the model using 2-(N,N-dipropyl)animo-5,6-dihydroxytetralin.
    Costall B; Naylor RJ; Owen RT
    Eur J Pharmacol; 1978 Jun; 49(4):407-13. PubMed ID: 352713
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The mesolimbic nucleus accumbens is critically involved with the mediation of the motor inhibitory and facilitatory effects of dopamine agonists on mouse spontaneous climbing behaviour.
    Costall B; Eniojukan JF; Naylor RJ
    Eur J Pharmacol; 1983 Dec; 96(3-4):201-10. PubMed ID: 6426976
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The mesolimbic system, denervation and the climbing response in the mouse.
    Costall B; Fortune DH; Naylor RJ; Nohria V
    Eur J Pharmacol; 1980 Aug; 66(2-3):207-15. PubMed ID: 6108225
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The production of asymmetry and circling behaviour following unilateral, intrastriatal administration of neuroleptic agents: a comparison of abilities to antagonise striatal function.
    Costall B; Kelly ME; Naylor RJ
    Eur J Pharmacol; 1983 Dec; 96(1-2):79-86. PubMed ID: 6141060
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of the abilities of typical neuroleptic agents and of thioridazine, clozapine, sulpiride and metoclopramide to antagonise the hyperactivity induced by dopamine applied intracerebrally to areas of the extrapyramidal and mesolimbic systems.
    Costall B; Naylor RJ
    Eur J Pharmacol; 1976 Nov; 40(1):9-19. PubMed ID: 791660
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of the nueroleptic properties of clozapine, sulpiride and thioridazine.
    Costall B; Naylor RJ
    Psychopharmacologia; 1975 Jul; 43(1):69-74. PubMed ID: 1172258
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Benzamides and classical neuroleptics: comparison of their actions using 6 apomorphine-induced effects.
    Puech AJ; Simon P; Boissier JR
    Eur J Pharmacol; 1978 Aug; 50(4):291-300. PubMed ID: 29758
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dopamine agonist action in mesolimbic, cortical and extrapyramidal areas to modify spontaneous climbing behaviour of the mouse.
    Costall B; Eniojukan JF; Naylor RJ
    Psychopharmacology (Berl); 1985; 86(4):452-7. PubMed ID: 3929317
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spontaneous climbing behaviour of mice, its measurement and dopaminergic involvement.
    Costall B; Eniojukan JF; Naylor RJ
    Eur J Pharmacol; 1982 Nov; 85(2):125-32. PubMed ID: 7151866
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuroleptic-induced reduction of quipazine-elicited head-twitches in rats: possible involvement of striatal dopaminergic supersensitivity.
    Dall'Olio R; Vaccheri A; Gandolfi O; Roncada P; Montanaro N
    Pharmacol Biochem Behav; 1988 Dec; 31(4):941-4. PubMed ID: 2908069
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atypical neuroleptics suppress dopaminergic behavioral supersensitivity.
    Schremmer C; Morgenstern R; Fink H; Ott T
    Psychopharmacology (Berl); 1990; 100(3):399-403. PubMed ID: 1969173
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased grooming behaviour is induced by apomorphine in mice treated with discriminant benzamide derivatives.
    Vasse M; Protais P
    Eur J Pharmacol; 1988 Oct; 156(1):1-11. PubMed ID: 2905270
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dopamine autoreceptor and postsynaptic receptor blocking potency of neuroleptics.
    Kendler KS; Bracha HS; Davis KL
    Eur J Pharmacol; 1982 Apr; 79(3-4):217-23. PubMed ID: 6124428
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Involvement of different dopamine receptors in rat diphasic motility response to apomorphine.
    Vaccheri A; Dall'Olio R; Gandolfi O; Montanaro N
    Psychopharmacology (Berl); 1986; 89(3):265-8. PubMed ID: 2873607
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of apomorphine-induced climbing in mice by cholinergic drugs and neuroleptics.
    Lassen JB
    Acta Pharmacol Toxicol (Copenh); 1979 Aug; 45(2):161-5. PubMed ID: 40391
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mirtazapine enhances the effect of haloperidol on apomorphine-induced climbing behaviour in mice and attenuates haloperidol-induced catalepsy in rats.
    Berendsen HH; Broekkamp CL; Pinder RM
    Psychopharmacology (Berl); 1998 Feb; 135(3):284-9. PubMed ID: 9498732
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Behavioural interactions between 5-hydroxytryptophan, neuroleptic agents and 5-HT receptor antagonists in modifying rodent responding to aversive situations.
    Costall B; Naylor RJ
    Br J Pharmacol; 1995 Dec; 116(7):2989-99. PubMed ID: 8680734
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Behavioral deficits induced by low doses of apomorphine in rats: evidence for a motivational and cognitive dysfunction which discriminates among neuroleptic drugs.
    Carnoy P; Ravard S; Wemerman B; Soubrie P; Simon P
    Pharmacol Biochem Behav; 1986 Sep; 25(3):503-9. PubMed ID: 2877466
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.